Vyne Therapeutics Inc.
VYNE
Revenue
202.00k
▲118.00k▲140.48%
3 Months ChangeAssets
56.42M
▼-10.48M▼-15.67%
3 Months ChangeLiabilities
12.29M
▼-2.53M▼-17.06%
3 Months ChangeFree Cash Flow
-12.55M
▲39.70M▲75.98%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-12
Form 8-K
ID: 0001104659-24-099121
2024-08-14
Form 10-Q
ID: 0001628280-24-037176
2024-08-14
Form 8-K
ID: 0001628280-24-037051
2024-05-09
Form 10-Q
ID: 0001628280-24-022183
2024-05-09
Form 8-K
ID: 0001628280-24-021971
2024-02-29
Form 8-K
ID: 0001104659-24-029097
2024-01-03
Form 8-K
ID: 0001104659-24-000584
2023-12-13
Form 8-K
ID: 0001104659-23-125694
2023-11-13
Form 10-Q
ID: 0001628280-23-038414
2023-11-13
Form 8-K
ID: 0001104659-23-116712